Publications While At Healthpartners
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
New England Journal of Medicine.
EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome
American Heart Journal.
Hypoglycemia is associated with increased risk of cardiovascular events: results from the EXAMINE Trial [abstract]
Mortality findings from the EXAMINE Trial [abstract]
Map of science